A pharmaceutical formulation that facilitates the enhanced dissolution of an alkaline salt of an oral absorption promoter contained therein, wherein the said pharmaceutical formulation comprises (1) a drug in the amount of about 0.01-85% (w/w) of the total amount of the pharmaceutical formulation, (2) an alkaline salt of an oral absorption promoter in the amount of about 5-98% (w/w) of the total amount of the pharmaceutical formulation, (3) an acid neutralizer in an amount of about 3.5-35% (w/w) of the total amount of the pharmaceutical formulation or in an amount that is at least sufficient to elevate the pH of mixture of 35 mL of 0.1N HCl and 125 ml of water from less than about 2 to at least about 2.5, and (4) optionally one or more pharmaceutically acceptable excipients,
- wherein the said pharmaceutical formulation, when subjected to an in vitro release test in the 160 mL of acidic medium having a pH of about 1.7, released the acid neutralizer prior to, concurrently with, or faster than the release of the alkaline salt of the oral absorption promoter, which facilitates marked improvement in the release or dissolution of the alkaline salt of the oral absorption promoter in the 160 mL of the acidic medium.